Potential role of selective COX-2 inhibitors in cancer management.

Oncology (Williston Park, N.Y.)

Volumn 16, Issue 5 Suppl 4, 2002, Pages 30-36

  Dang, Chau T ^a   Shapiro, Charles L ^a   Hudis, Clifford A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

CLINICAL TRIAL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; NEOPLASM; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0036560167     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)